Mary Figgatt

553 total citations
20 papers, 281 citations indexed

About

Mary Figgatt is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Infectious Diseases. According to data from OpenAlex, Mary Figgatt has authored 20 papers receiving a total of 281 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Public Health, Environmental and Occupational Health and 4 papers in Infectious Diseases. Recurrent topics in Mary Figgatt's work include Opioid Use Disorder Treatment (7 papers), Poisoning and overdose treatments (3 papers) and Antibiotic Use and Resistance (3 papers). Mary Figgatt is often cited by papers focused on Opioid Use Disorder Treatment (7 papers), Poisoning and overdose treatments (3 papers) and Antibiotic Use and Resistance (3 papers). Mary Figgatt collaborates with scholars based in United States. Mary Figgatt's co-authors include Nabarun Dasgupta, Louise Vincent, Anna E. Austin, Rebecca B. Naumann, David M. Dziewulski, Lloyd R. Wilson, Meghan E. Shanahan, Aaron Ferguson, Scott Proescholdbell and Shoshana V. Aronowitz and has published in prestigious journals such as Clinical Infectious Diseases, American Journal of Public Health and Epidemiology.

In The Last Decade

Mary Figgatt

20 papers receiving 274 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Figgatt United States 10 161 131 43 41 35 20 281
Lia Pizzicato United States 9 255 1.6× 180 1.4× 79 1.8× 50 1.2× 60 1.7× 19 416
Brittany Graham Canada 12 219 1.4× 194 1.5× 18 0.4× 49 1.2× 63 1.8× 24 379
Adam Holland United Kingdom 9 130 0.8× 143 1.1× 11 0.3× 41 1.0× 46 1.3× 18 261
Kathleen Creppage United States 8 195 1.2× 128 1.0× 12 0.3× 20 0.5× 21 0.6× 16 324
Rafik Wahbi United States 5 132 0.8× 65 0.5× 124 2.9× 36 0.9× 79 2.3× 7 285
Philip Huynh United States 11 303 1.9× 207 1.6× 8 0.2× 53 1.3× 55 1.6× 27 425
Olivia K. Sugarman United States 10 93 0.6× 62 0.5× 14 0.3× 51 1.2× 10 0.3× 31 235
Jessica Halverson Canada 8 265 1.6× 193 1.5× 6 0.1× 77 1.9× 34 1.0× 18 486
Miles Morris United States 12 259 1.6× 258 2.0× 5 0.1× 46 1.1× 90 2.6× 27 376
Sarah Ruiz United States 7 443 2.8× 255 1.9× 15 0.3× 44 1.1× 105 3.0× 7 533

Countries citing papers authored by Mary Figgatt

Since Specialization
Citations

This map shows the geographic impact of Mary Figgatt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Figgatt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Figgatt more than expected).

Fields of papers citing papers by Mary Figgatt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Figgatt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Figgatt. The network helps show where Mary Figgatt may publish in the future.

Co-authorship network of co-authors of Mary Figgatt

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Figgatt. A scholar is included among the top collaborators of Mary Figgatt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Figgatt. Mary Figgatt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schranz, Asher J, Mary Figgatt, Vivian H. Chu, Li‐Tzy Wu, & David L. Rosen. (2024). Long-Term Mortality After Drug Use-Associated Endocarditis is High and Differs by Race and Sex: Results of a Statewide Study. Drug and Alcohol Dependence. 260. 110566–110566. 1 indexed citations
2.
Figgatt, Mary, David L. Rosen, Vivian H. Chu, Li‐Tzy Wu, & Asher J Schranz. (2024). Long-term Risk of Serious Infections and Mortality Among Patients Surviving Drug Use–Associated Infective Endocarditis. Clinical Infectious Diseases. 79(1). 56–59. 2 indexed citations
3.
Bradford, W. David, et al.. (2024). Xylazine co-occurrence with illicit fentanyl is a growing threat in the Deep South: a retrospective study of decedent data. Harm Reduction Journal. 21(1). 9 indexed citations
4.
Figgatt, Mary, Juan M. Hincapie‐Castillo, Asher J Schranz, et al.. (2023). Medications for Opioid Use Disorder and Mortality and Hospitalization Among People With Opioid Use-related Infections. Epidemiology. 35(1). 7–15. 1 indexed citations
5.
6.
Figgatt, Mary, Asher J Schranz, Bradford E. Jackson, et al.. (2023). Mortality associated with bacterial and fungal infections and overdose among people with drug use diagnoses. Annals of Epidemiology. 87. 45–50.e14. 1 indexed citations
7.
Ferguson, Aaron, Mary Figgatt, Shoshana V. Aronowitz, et al.. (2023). Reducing the harms of xylazine: clinical approaches, research deficits, and public health context. Harm Reduction Journal. 20(1). 141–141. 44 indexed citations
8.
Figgatt, Mary, Asher J Schranz, Juan M. Hincapie‐Castillo, et al.. (2022). Complications in Using Real-World Data to Study the Health of People Who Use Drugs. Epidemiology. 34(2). 259–264. 2 indexed citations
9.
Ranapurwala, Shabbar I., Mary Figgatt, Carrie Brown, et al.. (2022). Opioid Overdose Deaths Among Formerly Incarcerated Persons and the General Population: North Carolina, 2000‒2018. American Journal of Public Health. 112(2). 300–303. 18 indexed citations
10.
Figgatt, Mary, Anna E. Austin, Mary E. Cox, et al.. (2021). Trends in unintentional polysubstance overdose deaths and individual and community correlates of polysubstance overdose, North Carolina, 2009-2018. Drug and Alcohol Dependence. 219. 108504–108504. 12 indexed citations
11.
Figgatt, Mary, et al.. (2021). Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19. Journal of Substance Abuse Treatment. 123. 108276–108276. 88 indexed citations
12.
Austin, Anna E., et al.. (2021). Associations of housing stress with later substance use outcomes: A systematic review. Addictive Behaviors. 123. 107076–107076. 24 indexed citations
13.
Figgatt, Mary, et al.. (2021). Treatment experiences for skin and soft tissue infections among participants of syringe service programs in North Carolina. Harm Reduction Journal. 18(1). 80–80. 13 indexed citations
14.
Figgatt, Mary, et al.. (2020). Susceptibility to Hepatitis A and B Virus Among Clients at a Syringe Services Program in Philadelphia, 2018. Public Health Reports. 135(5). 691–699. 10 indexed citations
15.
Figgatt, Mary, et al.. (2019). Chronic Disease Surveillance Using Electronic Health Records From Health Centers in a Large Urban Setting. Journal of Public Health Management and Practice. 27(2). 186–192. 7 indexed citations
16.
Figgatt, Mary, et al.. (2019). Inappropriate intravenous antimicrobial starts: An antimicrobial stewardship metric for hemodialysis facilities. Infection Control and Hospital Epidemiology. 40(10). 1178–1180. 5 indexed citations
17.
Figgatt, Mary, et al.. (2019). Geographic analysis of blood lead levels and neighborhood-level risk factors among children born in 2008-2010.. Journal of environmental health. 82(3). 18–24. 5 indexed citations
18.
Figgatt, Mary, et al.. (2017). Giardiasis Outbreak Associated with Asymptomatic Food Handlers in New York State, 2015. Journal of Food Protection. 80(5). 837–841. 10 indexed citations
19.
Figgatt, Mary, et al.. (2017). Harmful Algal Bloom–Associated Illnesses in Humans and Dogs Identified Through a Pilot Surveillance System — New York, 2015. MMWR Morbidity and Mortality Weekly Report. 66(43). 1182–1184. 15 indexed citations
20.
Figgatt, Mary, Neil Muscatiello, Lloyd R. Wilson, & David M. Dziewulski. (2016). Harmful Algal Bloom–Associated Illness Surveillance: Lessons From Reported Hospital Visits in New York, 2008–2014. American Journal of Public Health. 106(3). 440–442. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lia Pizzicato Breakdown of academic impact, for papers by Brittany Graham Breakdown of academic impact, for papers by Adam Holland Breakdown of academic impact, for papers by Kathleen Creppage Breakdown of academic impact, for papers by Rafik Wahbi Breakdown of academic impact, for papers by Philip Huynh Breakdown of academic impact, for papers by Olivia K. Sugarman Breakdown of academic impact, for papers by Jessica Halverson Breakdown of academic impact, for papers by Miles Morris Breakdown of academic impact, for papers by Sarah Ruiz
Rankless by CCL
2026